BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18541474)

  • 1. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
    Abbatiello SE; Pan YX; Zhou M; Wayne AS; Veenstra TD; Hunger SP; Kilberg MS; Eyler JR; Richards NG; Conrads TP
    J Proteomics; 2008 Apr; 71(1):61-70. PubMed ID: 18541474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies.
    Kusano-Arai O; Iwanari H; Mochizuki Y; Nakata H; Kodama T; Kitoh T; Hamakubo T
    Hybridoma (Larchmt); 2012 Oct; 31(5):325-32. PubMed ID: 23098298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
    Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
    Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
    Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
    Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
    Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
    Hermanova I; Zaliova M; Trka J; Starkova J
    Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
    Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
    Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
    Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
    J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of
    Watanabe A; Miyake K; Yamada Y; Sunamura EI; Yotani T; Kagami K; Kasai S; Tamai M; Harama D; Akahane K; Goi K; Sakaguchi K; Goto H; Kitahara S; Inukai T
    Epigenetics; 2023 Dec; 18(1):2268814. PubMed ID: 37839090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.
    Grima-Reyes M; Vandenberghe A; Nemazanyy I; Meola P; Paul R; Reverso-Meinietti J; Martinez-Turtos A; Nottet N; Chan WK; Lorenzi PL; Marchetti S; Ricci JE; Chiche J
    Sci Adv; 2022 Jul; 8(27):eabn6491. PubMed ID: 35857457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
    Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
    Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
    Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.
    Smallwood TL; Small GW; Suter SE; Richards KL
    Leuk Lymphoma; 2014 Jun; 55(6):1357-65. PubMed ID: 24033105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.
    He Y; Li B; Luo C; Shen S; Chen J; Xue H; Tang J; Gu L
    J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):159-163. PubMed ID: 21505976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
    Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
    Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
    Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
    Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
    Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
    Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.